🇺🇸 FDA

Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8680046

Inhibitors of viral integrase and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669081

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669249

Poly (ADP-ribose) polymerase (PARP) inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664251

Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

The Regents of the University of California · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664219

Aminopyrimidines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658669

Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653070

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653088

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8648037

Macrocyclic proline derived HCV serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642751

MicroRNA inhibitors comprising locked nucleotides

MIRAGEN THERAPEUTICS, INC. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642282

Inhibitors of nitric oxide synthase for treatment of melanoma

The Regents of the University of California · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642779

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637310

Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637568

Serotonin reuptake inhibitors

Theravance, Inc. · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637511

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637675

Inhibitors of proliferation and activation of signal transducer and activators of transcri

The Board of Regents of the University of Texas System · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637666

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8633205

Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8633210

Triazole compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8629156

Tryptophan hydroxylase inhibitors

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623867

Cyclic amine BACE-1 inhibitors having a benzamide substituent

Pharmacopeia Drug Discovery, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623869

Compounds useful as inhibitors of ATR kinase

Vertex Pharmaceuticals Incorporated · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618152

Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618090

Inhibitors of the plasmodial surface anion channel as antimalarials

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted